Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cancer, treatment using tyrosine kinase receptor inhibitors

AstraZeneca s gefitinib (Iressa) s core structure is a quinazoline. It is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) indicated for the treatment of cancers. Several other protein kinase inhibitors also used the quinazoline ring as their core structure. They include OSI s erlotinib (Tarceva) and GSK s lapatinib (Tykerb). [Pg.16]

See other pages where Cancer, treatment using tyrosine kinase receptor inhibitors is mentioned: [Pg.16]    [Pg.455]    [Pg.178]    [Pg.569]    [Pg.1257]    [Pg.149]    [Pg.469]    [Pg.506]    [Pg.67]    [Pg.186]    [Pg.92]    [Pg.1309]    [Pg.422]    [Pg.569]    [Pg.1257]    [Pg.460]    [Pg.218]    [Pg.151]    [Pg.639]    [Pg.607]    [Pg.1473]    [Pg.1619]    [Pg.51]    [Pg.331]    [Pg.454]    [Pg.399]    [Pg.299]    [Pg.31]    [Pg.416]    [Pg.189]   
See also in sourсe #XX -- [ Pg.555 ]



SEARCH



Cancer treatment

Cancer, treatment using

Cancer, treatment using inhibitors

Cancer, treatment using tyrosine kinase inhibitors

Inhibitors use

Kinase cancers

Kinase inhibitors

Kinase, kinases inhibitors

Receptor inhibitors

Receptor kinases

Receptor tyrosine kinase inhibitor

Receptor tyrosine kinases

Tyrosine inhibitors

Tyrosine kinases

Tyrosines tyrosine kinase

© 2024 chempedia.info